(Q39487822)

English

Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Shiomi M

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ito T

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Tsukada T

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Tsujita Y

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Horikoshi H

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

142

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

345-353

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determinations by a new sensitive immuno-assay technic

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Inhibition of oxidation of low density lipoprotein by troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Insulin resistance observed in WHHL rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Quantitative characterization of insulin-glucose response in Watanabe heritable hyperlipidemic and cholesterol-fed rabbits and the effect of cilazapril.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Cell compositions of coronary and aortic atherosclerotic lesions in WHHL rabbits differ. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Differential inhibitory effects of antidiabetic drugs on arterial smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Troglitazone has a scavenging effect on reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Importance of intra-abdominal visceral fat accumulation to coronary atherosclerosis in heterozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900259-7

7 January 2021

Identifiers

10.1016/S0021-9150(98)00259-7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

release_5pumya4jcraufhxtk4trg66lsa

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39487822&oldid=1830509282"